Retinal Vascular Disorders
View IssueApril 2010 | Feature Story
Novel Approaches to Neuroprotection
Computer modeling seeks new agents; sustained-release technology aims to improve the efficacy of an existing drug.
Jennifer Kreatsoulas, PHD, Senior Associate Editor
April 2010 | Business Of Retina
What It Takes To Be a Great Mentor
Darrell E. Baskin, MD; Jeremy D. Wolfe, MD; and Chirag P. Shah, MD, MPH
April 2010 | Retina Surgery
GLOBAL PERSPECTIVES: Verteporfin Photodynamic Therapy for AMD in the Anti-VEGF Era
There is still a role for PDT in exudative maculopathy, especially for polypoidal choroidal vasculopathy.
Adrian Koh, MD
April 2010 | Oncology
CASE REPORTS IN OCULAR ONCOLOGY: Visual Field Defects From Optic Disc Melanocytoma
Emil Anthony T. Say, MD; Neelema Sinha, MD; and Carol L. Shields, MD
April 2010 | Cover Story
Progress Report: The MacTel Project
At the 5-year mark of the collaboration, much has been learned, but still no treatment is available.
Mark C. Gillies, MB BS, PHD, FRANZCO
April 2010 | Medical Retina
Patient Assessment: Gel vs Liquid Anesthetic for Intravitreal Injections
There was a high degree of patient satisfaction with the procedure.
John S. Pollack, MD, and Michael J. Davis, MD
April 2010 | Retina Surgery
Wound Construction in 23-Gauge Surgery
Successful closure rates may be affected by the method of incision construction.
Keith A. Warren, MD
April 2010 | Business Of Retina
Academic Clinical Practice Enjoys Slow Growth in Stable Population Center
Participation in clinical trials allows first-rate patient care.
Robert L. Avery, MD
April 2010 | Departments
INNOVATIONS